Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Epang Palace Pharmaceutical is a well-established Chinese pharmaceutical company based in Xi'an, Shaanxi Province, specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and modern chemical drugs. The company's product portfolio is diverse, covering therapeutic areas such as gastroenterology, cardiovascular health, orthopedics, and respiratory medicine. Notable products include the Xiangsha Yangwei Pill and Gucixiaotong Capsule, which are recognized for their efficacy in treating digestive and musculoskeletal conditions. Epang Palace Pharmaceutical operates advanced manufacturing facilities that adhere to strict national Good Manufacturing Practice (GMP) standards. By integrating ancient herbal wisdom with modern pharmaceutical technology, the company has secured a significant presence in the domestic Chinese healthcare market. Their commitment to quality and innovation is reflected in their status as a high-tech enterprise with numerous proprietary formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xian Epang Place Pharmaceutical.